Hyperoxia causes miR199a-5p-mediated injury in the developing lung.

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Neonatology

Background:

• Hyperoxia-induced acute lung injury (HALI) impairs lung development and function.
• MicroRNAs (miRs) are increasingly recognized for their role in HALI and bronchopulmonary dysplasia (BPD).
• The specific role of miR199a-5p in developing lungs remains uncharacterized.

Purpose of the Study:

• To investigate the expression profile and functional significance of miR199a-5p in developing lungs under hyperoxic conditions.
• To explore the therapeutic potential of targeting miR199a-5p in HALI and BPD.

Main Methods:

• Neonatal mice, lung epithelial cells (MLE12), endothelial cells (MLECs), and macrophages (RAW246.7) were exposed to hyperoxia.
• miR199a-5p expression was analyzed in mouse lungs, cells, and infant tracheal aspirates.
• Functional studies involved miR199a-5p mimics and inhibitors to assess effects on HALI markers.

Main Results:

• miR199a-5p expression was significantly upregulated in hyperoxia-exposed lungs and cells, and in BPD infants.
• Expression of caveolin-1, a target of miR199a-5p, was reduced.
• miR199a-5p mimic administration exacerbated HALI, while miR199a-5p inhibitor treatment attenuated it.

Conclusions:

• miR199a-5p plays a critical role in the pathophysiology of HALI in developing lungs.
• Targeting miR199a-5p with inhibitors presents a promising therapeutic strategy for BPD in preterm neonates.